跳至主要内容
临床试验/CTRI/2024/08/072207
CTRI/2024/08/072207尚未招募不适用

A Randomized Controlled Clinical Trial to Study the effect of Snehapurvak Siravedha in Grudhrasi with special reference to Sciatica

Dr Akshaya Anil Toraskar1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2024年8月19日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
72
试验地点
1
主要终点
Reduction in signs and symptoms of Ghrudhrasi

研究概览

简要总结

The population based study from India to report on Grudhrasi shows that the prevalence of Grudhrasi was 14%. In this disease pain is severe and affects the  daily work and lifestyle, so there is a need to discover better and different treatment therapies in this painful condition. Present study of Randomized Controlled Clinical Trial will be carried out to study the effect of Snehapurvak Siravedha in Grudhrasi with special reference to Sciatica. For present study subjects between age group 30-60 years will be taken irrespective of religion, gender, socioeconomic status. Sample size found was 32, considering drop out rate of 10% 36 was decided. Total 72 patients will be taken for the study, 36 patients in group A (Trail group) and 36 patients in group B (Control Group). Snehapurvak Siravedha is taken in group A (Trial group) and Asnehapurvak Siravedha is taken in group B (Control Group). Group A will be given Goghrit in Vardhaman Matra of 30ml, 60ml, and 90ml for 3 days followed by Abhyanga, Swedana and then Siravedha on 4th day. Next 2nd sitting will be carried out after 7 days on 12th day with prior 3 days of Snehapana. For group B, only Abhyanga and Swedana followed by Siravedha on the same day will be done in 2 sittings. SOP will be followed, all findings will be entered in case record form. Observation will be drawn before, during and after treatment. Results will be drawn with the help of Statistical method. Discussion will be one on the basis of Observations. Summary will be drawn. Conclusion will be drawn strictly on the basis of Statistical Analysis and will be unbiased.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant Blinded

入排标准

年龄范围
30.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients having classical signs and symptoms of Grudhrasi like PadaKramat Vedana, Toda, Pada suptata.
  • Age between 30 years to 60 years.
  • Patients having confirmed the diagnosis by using SLR test.

排除标准

  • Patients with diabetes and cardiovascular disease, immunocompromised, traumatic, infective, neoplastic spine.
  • Anemic patients with Hb less then
  • Pregnant women.
  • Patients age below 30 years and above 60 years.
  • Anatomical deformities like varus, vulgus, kyphosis, lordosis, scoliosis, spina bifida etc.

结局指标

主要结局

Reduction in signs and symptoms of Ghrudhrasi

时间窗: 12 days

次要结局

  • where trial group is more effective than control group in reducing sign & symptoms of Grudhrasi(18 months)

研究者

发起方
Dr Akshaya Anil Toraskar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Akshaya Anil Toraskar

SMBT Ayurved College and Hospital Nandi Hills Dhamangaon Igatpuri Nashik

研究点 (1)

Loading locations...

相似试验